178 related articles for article (PubMed ID: 14766247)
21. Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival.
Pertschuk LP; Masood S; Simone J; Feldman JG; Fruchter RG; Axiotis CA; Greene GL
Gynecol Oncol; 1996 Oct; 63(1):28-33. PubMed ID: 8898164
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression].
Kieback DG; Press MF; McCamant SK; Atkinson EN; Möbus VJ; Runnebaum IB; Kreienberg R; Jones LA
Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):189-94. PubMed ID: 7789706
[TBL] [Abstract][Full Text] [Related]
23. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T
Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757
[TBL] [Abstract][Full Text] [Related]
24. [Histopathological changes in endometrial cancer treated with tamoxifen].
Lin HH; Ueda K; Kato J
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1038-43. PubMed ID: 3963849
[TBL] [Abstract][Full Text] [Related]
25. Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs.
Donnay I; Rauïs J; Devleeschouwer N; Wouters-Ballman P; Leclercq G; Verstegen J
Am J Vet Res; 1995 Sep; 56(9):1188-94. PubMed ID: 7486397
[TBL] [Abstract][Full Text] [Related]
26. Expression of estrogen and progesterone receptors in cytologic specimens using various fixatives.
Hudock JA; Hanau CA; Christen R; Bibbo M
Diagn Cytopathol; 1996 Jul; 15(1):78-83. PubMed ID: 8807259
[TBL] [Abstract][Full Text] [Related]
27. [Hormonal therapy of endometrial cancer].
Kato J
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1182-8. PubMed ID: 4057575
[TBL] [Abstract][Full Text] [Related]
28. [Cytosol estrogen and progesterone receptors in female genital system malignant tumors].
Han SW; He B; Tang QP
Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):12-5, 59. PubMed ID: 8033616
[TBL] [Abstract][Full Text] [Related]
29. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas.
Saegusa M; Kamata Y; Isono M; Okayasu I
J Pathol; 1996 Nov; 180(3):275-82. PubMed ID: 8958805
[TBL] [Abstract][Full Text] [Related]
30. Estrogen and progesterone receptor detection in neoplastic and non-neoplastic thyroid tissues.
Bur M; Shiraki W; Masood S
Mod Pathol; 1993 Jul; 6(4):469-72. PubMed ID: 8415594
[TBL] [Abstract][Full Text] [Related]
31. [Research on the relationship between estrogen receptor, progesterone receptor, cell proliferation associated antigen in uterine leiomyoma and nuclear body density of myoma, serum reproductive hormone concentrations].
Wu J; Cheng Y
Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):603-7. PubMed ID: 8745507
[TBL] [Abstract][Full Text] [Related]
32. Estrogen and progestin receptors in human uterus: reference ranges of clinical conditions.
van der Walt LA; Sanfilippo JS; Siegel JE; Wittliff JL
Clin Physiol Biochem; 1986; 4(3):217-28. PubMed ID: 3709038
[TBL] [Abstract][Full Text] [Related]
33. Luteinizing hormone releasing hormone, estrogen, and progesterone receptors in canine mammary lesions and tumor cell lines.
Sartin EA; Rahe CH; Wright JC; Sartin JL
Anticancer Res; 1995; 15(5B):2029-32. PubMed ID: 8572597
[TBL] [Abstract][Full Text] [Related]
34. Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.
Nazeer T; Church K; Amato C; Ambros RA; Rosano TG; Malfetano JH; Ross JS
Mod Pathol; 1994 May; 7(4):469-74. PubMed ID: 8066075
[TBL] [Abstract][Full Text] [Related]
35. Glutathione S-transferase activity in human breast tumors.
Colovai AI; Stoica A; Cinca SA; Marin M; Gruia M; Condrea I; Petrescu D; Dutu R
Neoplasma; 1992; 39(4):249-54. PubMed ID: 1436238
[TBL] [Abstract][Full Text] [Related]
36. Mutations of the estrogen receptor in endometrial carcinoma: evidence of an association with high tumor grade.
Assikis VJ; Bilimoria MM; Muenzner HD; Lurain JR; Jordan VC
Gynecol Oncol; 1996 Nov; 63(2):192-9. PubMed ID: 8910626
[TBL] [Abstract][Full Text] [Related]
37. Effects of interferon-beta on steroid receptors, prostaglandins and enzymatic activities in human endometrial cancer.
De Cicco Nardone F; Rossiello F; Iacopino F; Benedetto MT; Cinque B; Dell'Acqua S; Sica G
Anticancer Res; 1996; 16(1):161-9. PubMed ID: 8615603
[TBL] [Abstract][Full Text] [Related]
38. Steroid receptors in cystosarcoma phyllodes.
Brentani MM; Nagai MA; Oshima CT; Pacheco MM; Góes JC; Lemos LB
Cancer Detect Prev; 1982; 5(2):211-9. PubMed ID: 6290062
[TBL] [Abstract][Full Text] [Related]
39. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
Hatae M; Yagi Y
Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.
Budwit-Novotny DA; McCarty KS; Cox EB; Soper JT; Mutch DG; Creasman WT; Flowers JL; McCarty KS
Cancer Res; 1986 Oct; 46(10):5419-25. PubMed ID: 3756890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
